TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
CDNA

CareDx Inc

Healthcare · Diagnostics & Research

63.70$ +3.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

CareDx Inc (CDNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 132 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CDNA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
12 11 12 12 12 13 14 18 21 24 26 31 34 36 38 42 53 59 67 74 76 79 79 81 79 82 77 70 67 66 72 92 83 87 85 87 100 108 118 132 458
6.0 6.5 5.4 5.2 5.2 5.6 6.4 7.2 8.9 11 9.7 12 11 13 12 15 17 19 22 24 25 27 27 28 28 29 26 26 25 26 26 28 28 28 28 29 31 36 34 35 135
6.5 4.4 6.2 6.9 7.0 6.9 7.7 11 12 13 16 20 22 23 26 27 37 40 46 50 51 52 53 53 51 53 51 44 43 40 46 64 55 58 56 58 69 73 84 97 323
2.9 3.2 3.3 3.1 3.0 3.0 3.4 3.5 3.9 3.8 5.6 7.6 8.5 8.9 10 13 12 13 16 19 19 22 22 23 22 24 24 20 19 18 19 20 17 17 19 17 17 19 21 22 80
5.2 4.5 6.5 4.1 4.0 4.2 5.3 5.6 5.2 5.9 9.1 8.5 9.5 9.4 10 12 13 13 15 16 19 25 27 25 24 25 28 29 34 27 27 31 29 41 23 28 28 29 30 41 129
12 10 13 11 10 10 13 15 15 15 22 27 29 29 32 38 39 43 47 55 59 68 72 75 68 72 76 72 71 66 65 72 66 70 64 69 70 79 82 97 328
-4.9 -5.9 -8.5 -3.6 -3.9 -4.3 -5.2 -5.2 -2.7 -2.4 -5.4 -6.8 -6.7 -5.5 -5.8 -11 -2.9 -3.1 -0.9 -4.7 -8.7 -15 -19 -22 -17 -19 -24 -28 -29 -41 -19 -7.3 -10 -12 -8.0 -11 -0.2 -6.0 1.8 0.3 -4.2
0.6 0.5 0.8 1.7 1.7 1.7 2.7 0.4 0.4 0.2 0.3 0.3 0.0 1.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.5 1.2 1.9 0.5 2.9 – – – – – – – – – – – – –
-4.2 -16 -5.9 -4.4 -14 -33 -9.4 -14 -20 -4.1 -8.1 -8.1 -2.8 -5.0 -6.1 -6.9 -3.1 -3.7 -1.0 -2.0 -12 -17 -20 -22 -17 -18 -24 -25 -24 -118 -17 -4.6 -7.2 88 -10 -8.7 1.7 -3.8 2.8 115 115
-0.4 -0.7 -0.3 -0.4 -0.2 -0.9 -0.4 -0.4 -0.3 -0.3 -0.6 -0.2 -0.9 -0.2 -0.3 -0.3 -0.2 -0.2 -0.3 -0.1 -0.2 -0.9 0.0 0.0 0.3 0.2 0.1 -0.1 -0.1 0.2 -0.1 0.0 0.2 -0.2 0.1 -0.1 0.0 0.3 0.0 3.9 4.2
-3.8 -15 -5.6 -4.0 -14 -32 -9.0 -14 -20 -3.8 -7.5 -7.8 -1.8 -4.8 -5.8 -6.6 -2.8 -3.5 -0.7 -1.9 -12 -16 -20 -22 -17 -18 -24 -25 -23 -118 -17 -4.6 -7.4 78 -10 -8.6 1.7 -4.1 2.8 111 111
-2.6 -5.1 -4.2 -1.8 -12 -2.3 -4.1 -3.4 -1.7 -2.3 -4.2 -5.8 -5.3 -3.9 -3.5 -3.7 -0.5 -0.5 1.8 0.8 -9.0 -14 -16 -18 -12 -14 -19 -22 -19 -36 -12 0.4 -2.3 -7.2 -3.1 -5.7 4.9 -0.8 7.1 4.3 16

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?